Lv3
380 积分 2023-04-30 加入
Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial
2小时前
待确认
Self-supervised based clustering for retinal optical coherence tomography images
28天前
已关闭
Guidelines for Reporting Outcomes in Trial Protocols
1个月前
已完结
INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN
1个月前
已完结
Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy: the ATLANTIC study
2个月前
已完结
Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy
2个月前
已完结
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
2个月前
已完结
HAWK and HARRIER
2个月前
已完结
YOSEMITE and RHINE
3个月前
已完结
Short-Term Morphofunctional Changes in Previously Treated Neovascular AMD Eyes Switched to Brolucizumab
4个月前
已完结
皖公网安备34019202002308
